FDA rejects autism use for drug its own commissioner promoted, approves it only for rare genetic condition affecting fewer than one in a million.
Prescriptions jumped 71% after promotion
Read the full story at Ars Technica
From the March 10, 2026 GovBrief, every story that day in one place.